Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Ailon Pharma Oy
OY
Active
Y-tunnus 3157653-9
Tykistökatu 4A-4565, 20520
Turku
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2020 · 5 years old
2 employees
www.ailonpharma.fi
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Ailon Pharma Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
1M
1M
1M
0M
0M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 1M
1M
2024
2025: 1M (0% vs 2024)
1M
0%
2025
EBITDA
EUR millions
11M
8M
6M
3M
0M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 9M
9M
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
2025: 0M
0M
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
867
658
356
−1
23
Staff expenses
−168
−122
−47
−23
−12
EBITDA
158
65
8 824
−74
−5
Depreciation & amort.
−68
−22
−6
−2
—
EBIT
91
43
8 818
−76
−5
Net financials
−21
−16
−13
−6
−2
Profit before tax
70
27
7 537
−82
−8
Tax
15
3
−0
−0
−0
Net profit
55
23
7 537
−82
−8
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
495
322
252
119
145
Equity
102
49
25
−50
32
Long-term debt
230
176
144
137
94
Short-term debt
162
97
82
32
19
Total debt
393
274
226
169
112
Financial ratios
5-year trend
EBITDA margin
18,3 %
This company
15,8 %
Market median
This company
Market median
16% above market
2021
2025
Equity ratio
20,6 %
This company
38,2 %
Market median
This company
Market median
46% below market
2021
2025
Return on equity
54,4 %
This company
18,4 %
Market median
This company
Market median
196% above market
2021
2025
Net profit margin
6,4 %
This company
8,1 %
Market median
This company
Market median
21% below market
2021
2025
Asset turnover
1,75×
This company
1,12×
Market median
This company
Market median
56% above market
2021
2025
Debt / equity
3,85×
This company
0,62×
Market median
This company
Market median
521% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-10-01 – 2021-09-30
View
PDF
More on Ailon Pharma Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
